Vitamin U, S-methylmethionine supplement
500 mg per capsule, 60 capsules. Made in the USA, third-party tested.
$49
Shop now
Vitamin U, also known as S-methylmethionine (SMM), is a compound studied for supporting the stomach's mucosal lining, and like any supplement, it fits some situations better than others. This post covers who the research and the official safety record point to as a good fit, and who should talk to a doctor before starting.
Who the research is built around
The human clinical trials on SMM were conducted in specific populations, and that's worth knowing before deciding if it's relevant to you. The full research record is compiled in the Global Vitamin U Research Database.
Chronic gastritis patients are the closest match. The 2023 Drozdov trial followed adults with chronic gastritis taking 300 mg/day for six months, with symptom improvements building over that period. (1)
People with NSAID-related gastric irritation are another documented group. The 1993 Salim trial tested SMM in patients with active NSAID-induced gastric bleeding, at a much higher acute dose (500 mg four times daily) than typical daily supplementation. (2)
More broadly, the compound has decades of use in Japan as a prescription and over-the-counter medicine for gastritis, peptic ulcers and general stomach discomfort in adults, and decades of use in Ukraine as a supplement. If you fall into one of these groups, meaning an adult managing chronic gastritis, occasional stomach irritation from NSAIDs, or general interest in mucosal support, you're in the population the existing research actually describes.
Who should check with a doctor first
A few groups don't have dedicated research, and the compound's own regulatory documentation in Japan is specific about this. The Cabagin U Kowa Tablets 25mg drug interview form, the official pharmaceutical filing for the Japanese prescription form of SMM, lists precautions for several patient categories. (3)
Pregnant women. No clinical trials have specifically studied SMM during pregnancy, so there's no dedicated safety data for this group yet. That's routine for most supplements, not a documented risk. It just means an OB should be part of the decision before starting.
Breastfeeding women. Same situation: no dedicated studies exist on SMM during breastfeeding. Check with a doctor first, the same standard advice that applies to starting any new supplement while breastfeeding.
Children. The filing states plainly that no clinical trials evaluating efficacy and safety in pediatric patients have been conducted. There is no age-appropriate dosing or safety data for children. This isn't a product for a child without a pediatrician's guidance.
Older adults. The filing recommends caution, including possible dose reduction, since physiological function is generally reduced in this population. This is common pharmaceutical guidance for many compounds, not something specific to SMM, but it's worth raising with a doctor before starting, especially at the higher end of the studied dose range.
People with kidney or liver disease. There's no specific research on SMM in these populations, in the human trials or in the Japanese regulatory filing. The absence of documented harm in healthy trial participants and animal models isn't the same as studied safety in people with existing organ conditions, so medical oversight is the sensible approach here.
People on medications with narrow therapeutic windows. This includes blood thinners, thyroid medications, and certain antidepressants. SMM acts as a methyl donor in the body, and no formal drug interaction studies have been published for this compound with any prescription medication. If you take medication in this category, mention any new supplement to the prescribing doctor first.
What the official safety record does and doesn't say
It's worth being precise about what the regulatory filing actually contains, because both overstating and understating it would be misleading.
The filing lists no absolute contraindications for any patient group. It also lists no prohibited or cautioned drug combinations in its official interactions section. Documented side effects are limited to hypersensitivity reactions like rash, and digestive effects like constipation, diarrhea, or belching, each occurring in under 0.1% of cases reviewed. (3)
None of this amounts to a safety guarantee for every person in every situation, and it isn't a substitute for a doctor's judgment about your specific health picture. What it does show is a compound without red flags in the categories regulators specifically require pharmaceutical filings to address, reviewed across a real prescription drug history rather than an unregulated supplement with no such record.
Summary
For an adult managing chronic gastritis, occasional NSAID-related stomach irritation, or general interest in mucosal support, Vitamin U sits in the population the clinical research and decades of prescription use actually describe. For pregnancy, breastfeeding, childhood, older age, existing kidney or liver conditions, or medications with a narrow safety margin, the honest answer is the same one any careful supplement recommendation should give: check with a doctor first, since dedicated data for those situations doesn't exist yet.
See the dosage guide for how much and when, the side effects guide for the full safety picture, and the product page for ingredient details.
This article is for informational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new supplement, especially if you have a health condition, are pregnant or breastfeeding, or take medications.
This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
References:
1. Drozdov VN, et al. Effect of 6-Month S-Methylmethionine Intake on the Quality of Life and Dyspepsia Symptoms in Patients with Chronic Gastritis. 2023. View on PubMed
2. Salim AS. Sulfhydryl-Containing Agents in the Treatment of Gastric Bleeding Induced by Nonsteroidal Anti-Inflammatory Drugs. 1993. View on PubMed
3. Cabagin U Kowa Tablets 25mg drug interview form (manufacturer regulatory filing), 8th ed. Kowa Company, Ltd. 2024. View source
*This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.